冠状动脉周围脂肪组织脂肪衰减系数的影响因素及其回归模型
作者:
作者单位:

(哈尔滨医科大学附属第一医院心血管内科,黑龙江省哈尔滨市 150001)

作者简介:

王弘宇,博士研究生,主要研究方向为冠状动脉粥样硬化的发病机制及诊疗,E-mail:781590815@qq.com。通信作者田野,博士后,主任医师,教授,博士研究生导师,主要从事声动力治疗相关心血管疾病的疗效与机制探究,致力于医、理、工多学科交叉和转化研究,E-mail:yetian6@163.com。

基金项目:

国家自然科学基金项目(81727809)


Influencing factors and regression model of the fat attenuation index of pericoronary adipose tissue
Author:
Affiliation:

Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang 150001, China)

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    目的]探究冠状动脉局部无炎症或轻度炎症时冠状动脉周围脂肪组织(PCAT)的脂肪衰减系数(FAI-PCAT)的影响因素并建立可预测其基础值的回归模型。 [方法]入选哈尔滨医科大学附属第一医院2019年1月—12月既往无冠心病病史、行冠状动脉计算机断层扫描血管造影(CCTA)检查排除梗阻性冠状动脉疾病的住院患者。收集患者基线资料和临床指标包括性别、年龄、身高、体质量、既往病史以及血常规、血糖、血脂等。由一名具有3年以上影像学阅片经验的医师应用AW VolumeShare 4 CT工作软件进行CCTA图像后处理,测量并记录FAI-PCAT值和心外膜脂肪衰减(EFat值)。采用Spearman相关性检验分析各因素相关性,采用多元线性回归分析FAI-PCAT的影响因素并建立回归模型。 [结果]共纳入103例CCTA显示CAD-RADS 0~1级的患者。FAI-PCAT值为(-82.2±7.0) Hu,EFat值为(-84.8±4.4) Hu。相关性分析显示FAI-PCAT值与EFat值呈显著正相关(P<0.01),与淋巴细胞/单核细胞比值(LMR)、淋巴细胞百分比呈显著负相关(P<0.01),与血糖水平呈正相关(P<0.05),与体质指数(BMI)、血脂各项指标不具有相关性;EFat值与BMI、甘油三酯(TG)、低密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值(LDLC/HDLC)、极低密度脂蛋白胆固醇(VLDLC)水平呈显著负相关(P<0.01),与HDLC呈显著正相关(P<0.01),与载脂蛋白A/载脂蛋白B比值(ApoA/ApoB)呈正相关(P<0.05)。多元线性回归分析显示EFat值(X1)、LMR(X2)和血糖水平(X3)是冠状动脉局部无炎症或轻度炎症时FAI-PCAT值()的主要影响因素和预测参数,回归方程为=-25.466+0.686X1-0.9X2+1.207X3。 [结论]冠状动脉局部无炎症或轻度炎症时EFat值、LMR和血糖水平是影响FAI-PCAT值的主要因素,回归模型可预测患者个体化的FAI-PCAT基础值。

    Abstract:

    Aim To explore the influencing factors of fat attenuation index of pericoronary adipose tissue (FAI-PCAT) when there is no local inflammation or mild inflammation of coronary artery, and to establish a regression model to predict the individual baseline values of FAI-PCAT. Methods Hospitalized patients who had no previous history of coronary heart disease and underwent coronary computed tomography angiography (CCTA) examination to exclude obstructive coronary artery disease in the First Affiliated Hospital of Harbin Medical University from January to December 2019 were included. The baseline data and clinical indexes such as sex, age, height, weight, past medical history, blood routine, blood glucose, and blood lipid were collected. The AW VolumeShare 4 CT working software was used to post-process the CCTA images by one doctor with more than 3 years of imaging experience, and FAI-PCAT and epicardial fat attenuation (EFat) were measured and recorded. Spearman correlation was used to analyze the correlation of factors. Multiple linear regression was used to analyze the influencing factors of FAI-PCAT and then established a regression model. Results A total of 103 patients with CCTA showing CAD-RADS 0~1 were included. The FAI-PCAT value is (-82.2±7.0) Hu, the EFat value is (-84.8±4.4) Hu. Correlation analysis showed that FAI-PCAT was significantly and positively correlated with EFat (P<0.01), significantly and negatively correlated with lymphocyte to monocyte ratio (LMR), lymphocyte percentage (P<0.01), and positively correlated with blood glucose level (P<0.05). There was no correlation between FAI-PCAT and body mass index (BMI), blood lipid. The EFat was significantly and negatively correlated with BMI, triglyceride (TG), low density lipoprotein cholesterol/high density lipoprotein cholesterol (LDLC/HDLC), very low density lipoprotein cholesterol (VLDLC) (P<0.01), and significantly and positively correlated with HDLC (P<0.01), positively correlated with apolipoprotein A/apolipoprotein B (ApoA/ApoB) (P<0.05). Multiple linear regression analysis showed that EFat value (X1), LMR (X2), and blood glucose level (X3) were the main influencing factors and prediction parameters of FAI-PCAT value when there was no local inflammation or mild inflammation of coronary artery, and the regression equation was =-25.466+0.686X1-0.9X2+1.207X3. Conclusion EFat value, LMR, and blood glucose level were the main influencing factors of FAI-PCAT value when there was no local inflammation or mild inflammation of coronary artery, and the regression model can predict the individual baseline values of FAI-PCAT.

    参考文献
    [1] 王弘宇, 田野.血管外膜在冠状动脉粥样硬化发病机制中的新进展.中国动脉硬化杂志, 1,9(10):896-902.WANG H Y, TIAN Y.Recent advances in the pathogenesis of coronary atherosclerosis in the adventitia of arteries.Chin J Arterioscler, 1,9(10):896-902.
    [2] MANCIO J, OIKONOMOU E K, ANTONIADES C.Perivascular adipose tissue and coronary atherosclerosis.Heart, 8,4(20):1654-1662.
    [3] ANTONOPOULOS A S, SANNA F B, SABHARWAL N, et al.Detecting human coronary inflammation by imaging perivascular fat.Sci Transl Med, 7,9(398):eaal2658.
    [4] TANAKA K, SATA M S T.Roles of perivascular adipose tissue in the pathogenesis of atherosclerosis.Front Physiol, 8,9:3.
    [5] ANTONIADES C, KOTANIDIS C P, BERMAN D S.State-of-the-art review article.Atherosclerosis affecting fat:What can we learn by imaging perivascular adipose tissue?.J Cardiovasc Comput Tomogr, 9,3(5):288-296.
    [6] LIN A, DEY D, WONG D T L, et al.Perivascular adipose tissue and coronary atherosclerosis:from biology to imaging phenotyping.Curr Atheroscler Rep, 9,1(12):47.
    [7] OIKONOMOU E K, MARWAN M, DESAI M Y, et al.Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study):a post-hoc analysis of prospective outcome data.Lancet, 8,2(10151):929-939.
    [8] GOELLER M, ACHENBACH S, CADET S, et al.Pericoronary adipose tissue computed tomography attenuation and high-risk plaque characteristics in acute coronary syndrome compared with stable coronary artery disease.JAMA Cardiol, 8,3(9):858-863.
    [9] GOELLER M, TAMARAPPOO B K, KWAN A C, et al.Relationship between changes in pericoronary adipose tissue attenuation and coronary plaque burden quantified from coronary computed tomography angiography.Eur Heart J Cardiovasc Imaging, 9,0(6):636-643.
    [10] GOELLER M, ACHENBACH S, MARWAN M, et al.Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects.J Cardiovasc Comput Tomogr, 8,2(1):67-73.
    [11] CURY R C, ABBARA S, ACHENBACH S, et al.CAD-RADS(TM) coronary artery disease-reporting and data system.An expert consensus document of the society of cardiovascular computed tomography (SCCT), the American college of radiology (ACR) and the North American society for cardiovascular imaging (NASCI).Endorsed by the American college of cardiology.J Cardiovasc Comput Tomogr, 6,0(4):269-281.
    [12] DAI X, DENG J H, YU M M, et al.Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography:relationship with serum inflammatory marker level.Int J Cardiovasc Imaging, 0,6(4):723-730.
    [13] CAMARENA V, SANT D, MOHSENI M, et al.Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue.Nutr Metab Cardiovasc Dis, 7,7(8):739-750.
    [14] LIU Z H, WANG S J, WANG Y Q, et al.Association of epicardial adipose tissue attenuation with coronary atherosclerosis in patients with a high risk of coronary artery disease.Atherosclerosis, 9,4:230-236.
    [15] HELL M M, DING X W, RUBEAUX M, et al.Epicardial adipose tissue volume but not density is an independent predictor for myocardial ischemia.J Cardiovasc Comput Tomogr, 6,0(2):141-149.
    [16] VERHAGEN S N, VISSEREN F L J.Perivascular adipose tissue as a cause of atherosclerosis.Atherosclerosis, 1,4(1):3-10.
    [17] IACOBELLIS G.Local and systemic effects of the multifaceted epicardial adipose tissue depot.Nat Rev Endocrinol, 5,1(6):363-371.
    [18] RAGGI P, GADIYARAM V, ZHANG C, et al.Statins reduce epicardial adipose tissue attenuation independent of lipid lowering:a potential pleiotropic effect.J Am Heart Assoc, 9,8(12):e013104.
    [19] CHATTERJEE T K, ARONOW B J, TONG W S, et al.Human coronary artery perivascular adipocytes overexpress genes responsible for regulating vascular morphology, inflammation, and hemostasis.Physiol Genomics, 3,5(16):697-709.
    [20] SPIROGLOU S G, KOSTOPOULOS C G, VARAKIS J N, et al.Adipokines in periaortic and epicardial adipose tissue:differential expression and relation to atherosclerosis.J Atheroscler Thromb, 0,7(2):115-130.
    [21] 吕俊兴, 许海燕.白细胞分类计数在急性冠状动脉综合征预后评估中的研究进展.中国动脉硬化杂志, 1,9(7):635-640.Lü J X, XU H Y.Research progress of leukocyte differential count in prognosis evaluation of acute coronary syndrome.Chin J Arterioscler, 1,9(7):635-640.
    [22] AKPEK M, KAYA M G, LAM Y Y, et al.Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.Am J Cardiol, 2,0(5):621-627.
    [23] 徐娜, 唐晓芳, 许晶晶, 等.中性粒细胞与淋巴细胞比值对急性心肌梗死合并多支血管病变患者远期预后的预测价值.中华心血管病杂志, 9,7(1):42-48.XU N, TANG X F, XU J J, et al.Predictive value of neutrophil to lymphocyte ratio on long-term outcomes of acute myocardial infarction patients with multivessel disease.Chin J Cardiol, 9,7(1):42-48.
    [24] LIN G L, DAI C Z, XU K Z, et al.Predictive value of neutrophil to lymphocyte ratio and red cell distribution width on death for ST segment elevation myocardial infarction.Sci Rep, 1,1(1):11506.
    [25] KOSE N, AKIN F, YILDIRIM T, et al.The association between the lymphocyte-to-monocyte ratio and coronary artery disease severity in patients with stable coronary artery disease.Eur Rev Med Pharmacol Sci, 9,3(6):2570-2575.
    [26] WANG Q, MA J F, JIANG Z Y, et al.Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction.Medicine (Baltimore), 7,6(34):e7897.
    [27] CREWE C, AN Y A, SCHERER P E.The ominous triad of adipose tissue dysfunction:inflammation, fibrosis, and impaired angiogenesis.J Clin Invest, 7,7(1):74-82.
    [28] CHONDRONIKOLA M, VOLPI E, BRSHEIM E, et al.Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans.Diabetes, 4,3(12):4089-4099.
    [29] WANG Z C, WANG Q A, LIU Y, et al.Energy metabolism in brown adipose tissue.FEBS J, 1,8(12):3647-3662.
    [30] GANDOY-FIEIRAS N, GONZALEZ-JUANATEY J R, EIRAS S.Myocardium metabolism in physiological and pathophysiological states:implications of epicardial adipose tissue and potential therapeutic targets.Int J Mol Sci, 0,1(7):2641.
    引证文献
引用本文

王弘宇,王腾玉,尹德春,田野.冠状动脉周围脂肪组织脂肪衰减系数的影响因素及其回归模型[J].中国动脉硬化杂志,2023,31(5):411~418.

复制
分享
文章指标
  • 点击次数:587
  • 下载次数: 807
历史
  • 收稿日期:2022-08-09
  • 最后修改日期:2023-02-02
  • 在线发布日期: 2023-05-19